Search research articles
Contact Us
Filters
Showing results (101-110 of 178) with videos related to
Page
of 18
Sort By:
Leukemia & Lymphoma
|
December 1, 2012
Early versus delayed autologous stem cell transplant in patients receiving novel therapies for multiple myeloma
Neil C Dunavin, Lai Wei, Patrick Elder, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 5, 2017
Serum miR-29a Is Upregulated in Acute Graft-versus-Host Disease and Activates Dendritic Cells through TLR Binding
Parvathi Ranganathan, Apollinaire Ngankeu, Nina C Zitzer, et al.
Hematological Oncology
|
March 2, 2011
Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic haematopoietic cell transplantation following fludarabine, busulfan-based reduced toxicity conditioning
Mehdi Hamadani, Michael Craig, Gary S Phillips, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 8, 2007
Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemia
William Blum, Rebecca B Klisovic, Bjoern Hackanson, et al.
British Journal of Haematology
|
October 24, 2006
Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project
Charles L Bennett, Andrew M Evens, Leslie A Andritsos, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 9, 2016
Granulocyte Colony-Stimulating Factor-Mobilized Allografts Contain Activated Immune Cell Subsets Associated with Risk of Acute and Chronic Graft-versus-Host Disease
Sumithira Vasu, Susan Geyer, Anissa Bingman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 14, 2016
Erratum to "Granulocyte Colony-Stimulating Factor-Mobilized Allografts Contain Activated Immune Cell Subsets Associated with Risk of Acute and Chronic Graft-versus-Host Disease" [Biol Blood Marrow Transplant 22(2016):658-668]
Sumithira Vasu, Susan Geyer, Anissa Bingman, et al.
Blood
|
May 13, 2010
The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody
Don M Benson, Courtney E Bakan, Anjali Mishra, et al.
Cancer
|
March 1, 2014
Complete response to induction therapy in patients with Myc-positive and double-hit non-Hodgkin lymphoma is associated with prolonged progression-free survival
Jonathon B Cohen, Susan M Geyer, Gerard Lozanski, et al.
Frontiers in Oncology
|
November 1, 2021
Inhibition of Bromodomain and Extra Terminal (BET) Domain Activity Modulates the IL-23R/IL-17 Axis and Suppresses Acute Graft-<i>Versus</i>-Host Disease
Katiri J Snyder, Hannah K Choe, Yandi Gao, et al.
Page
of 18
Search research articles
Search
Showing results (101-110 of 178) with videos related to
Sort By:
Page
of 18
Leukemia & Lymphoma
|
December 1, 2012
Early versus delayed autologous stem cell transplant in patients receiving novel therapies for multiple myeloma
Neil C Dunavin, Lai Wei, Patrick Elder, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 5, 2017
Serum miR-29a Is Upregulated in Acute Graft-versus-Host Disease and Activates Dendritic Cells through TLR Binding
Parvathi Ranganathan, Apollinaire Ngankeu, Nina C Zitzer, et al.
Hematological Oncology
|
March 2, 2011
Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic haematopoietic cell transplantation following fludarabine, busulfan-based reduced toxicity conditioning
Mehdi Hamadani, Michael Craig, Gary S Phillips, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 8, 2007
Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemia
William Blum, Rebecca B Klisovic, Bjoern Hackanson, et al.
British Journal of Haematology
|
October 24, 2006
Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project
Charles L Bennett, Andrew M Evens, Leslie A Andritsos, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 9, 2016
Granulocyte Colony-Stimulating Factor-Mobilized Allografts Contain Activated Immune Cell Subsets Associated with Risk of Acute and Chronic Graft-versus-Host Disease
Sumithira Vasu, Susan Geyer, Anissa Bingman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 14, 2016
Erratum to "Granulocyte Colony-Stimulating Factor-Mobilized Allografts Contain Activated Immune Cell Subsets Associated with Risk of Acute and Chronic Graft-versus-Host Disease" [Biol Blood Marrow Transplant 22(2016):658-668]
Sumithira Vasu, Susan Geyer, Anissa Bingman, et al.
Blood
|
May 13, 2010
The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody
Don M Benson, Courtney E Bakan, Anjali Mishra, et al.
Cancer
|
March 1, 2014
Complete response to induction therapy in patients with Myc-positive and double-hit non-Hodgkin lymphoma is associated with prolonged progression-free survival
Jonathon B Cohen, Susan M Geyer, Gerard Lozanski, et al.
Frontiers in Oncology
|
November 1, 2021
Inhibition of Bromodomain and Extra Terminal (BET) Domain Activity Modulates the IL-23R/IL-17 Axis and Suppresses Acute Graft-<i>Versus</i>-Host Disease
Katiri J Snyder, Hannah K Choe, Yandi Gao, et al.
Page
of 18